Crossmark

Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease

Published Online: 2022-10-18

Published Print: 2023-01

Authors

Nowell, Joseph

Blunt, Eleanor

Edison, Paul https://orcid.org/0000-0002-6551-2002
License Information

Text and Data Mining valid from 2022-10-18

Version of Record valid from 2022-10-18
More Information

Article History

Received: 13 October 2021

Revised: 6 September 2022

Accepted: 9 September 2022

First Online: 18 October 2022

Competing interests

: The authors declare no competing interests.

Document is current